Gabrielle Grubbs

1.1k total citations
21 papers, 418 citations indexed

About

Gabrielle Grubbs is a scholar working on Infectious Diseases, Animal Science and Zoology and Epidemiology. According to data from OpenAlex, Gabrielle Grubbs has authored 21 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 7 papers in Animal Science and Zoology and 6 papers in Epidemiology. Recurrent topics in Gabrielle Grubbs's work include SARS-CoV-2 and COVID-19 Research (14 papers), COVID-19 Clinical Research Studies (8 papers) and Animal Virus Infections Studies (7 papers). Gabrielle Grubbs is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (14 papers), COVID-19 Clinical Research Studies (8 papers) and Animal Virus Infections Studies (7 papers). Gabrielle Grubbs collaborates with scholars based in United States, China and Uganda. Gabrielle Grubbs's co-authors include Surender Khurana, Hana Golding, Juanjie Tang, Supriya Ravichandran, Bernice E. Eddy, Elizabeth M. Coyle, Laura Klenow, Robert D. Young, Youri Lee and Tony T. Wang and has published in prestigious journals such as Nature Communications, Blood and Nature Immunology.

In The Last Decade

Gabrielle Grubbs

20 papers receiving 396 citations

Peers

Gabrielle Grubbs
Tim I. Breugem Netherlands
Rowa Y. Alhabbab Saudi Arabia
Janine Mihm Germany
Christopher E. Yi United States
For Yue Tso United States
Tim I. Breugem Netherlands
Gabrielle Grubbs
Citations per year, relative to Gabrielle Grubbs Gabrielle Grubbs (= 1×) peers Tim I. Breugem

Countries citing papers authored by Gabrielle Grubbs

Since Specialization
Citations

This map shows the geographic impact of Gabrielle Grubbs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabrielle Grubbs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabrielle Grubbs more than expected).

Fields of papers citing papers by Gabrielle Grubbs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabrielle Grubbs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabrielle Grubbs. The network helps show where Gabrielle Grubbs may publish in the future.

Co-authorship network of co-authors of Gabrielle Grubbs

This figure shows the co-authorship network connecting the top 25 collaborators of Gabrielle Grubbs. A scholar is included among the top collaborators of Gabrielle Grubbs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gabrielle Grubbs. Gabrielle Grubbs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bellusci, Lorenza, et al.. (2024). Evolution of the Antigenic Landscape in Children and Young Adults with COVID-19 and MIS-C. Vaccines. 12(6). 638–638.
2.
Khurana, Surender, Gabrielle Grubbs, Supriya Ravichandran, et al.. (2024). Longitudinal proteome-wide antibody profiling in Marburg virus survivors identifies wing domain immunogen for vaccine design. Nature Communications. 15(1). 8133–8133. 2 indexed citations
3.
Lee, Youri, Laura Klenow, Elizabeth M. Coyle, et al.. (2024). Monoclonal antibodies targeting sites in respiratory syncytial virus attachment G protein provide protection against RSV-A and RSV-B in mice. Nature Communications. 15(1). 2900–2900. 9 indexed citations
4.
Bellusci, Lorenza, Gabrielle Grubbs, Lael M. Yonker, et al.. (2023). Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children. Nature Communications. 14(1). 7952–7952. 3 indexed citations
5.
Parsons, Lisa M., Olga Zoueva, Gabrielle Grubbs, et al.. (2023). Glycosylation of H4 influenza strains with pandemic potential and susceptibilities to lung surfactant SP-D. Frontiers in Molecular Biosciences. 10. 1207670–1207670. 2 indexed citations
6.
Bellusci, Lorenza, Gabrielle Grubbs, Fatema Tuz Zahra, et al.. (2022). Antibody affinity and cross-variant neutralization of SARS-CoV-2 Omicron BA.1, BA.2 and BA.3 following third mRNA vaccination. Nature Communications. 13(1). 4617–4617. 38 indexed citations
8.
Grubbs, Gabrielle, et al.. (2022). Insect cell expression and purification of recombinant SARS‐COV‐2 spike proteins that demonstrate ACE2 binding. Protein Science. 31(5). e4300–e4300. 11 indexed citations
9.
Bellusci, Lorenza, Gabrielle Grubbs, Pragya Srivastava, et al.. (2022). Neutralization of SARS-CoV-2 Omicron after vaccination of patients with myelodysplastic syndromes or acute myeloid leukemia. Blood. 139(18). 2842–2846. 7 indexed citations
10.
Tang, Juanjie, Youri Lee, Supriya Ravichandran, et al.. (2021). Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern. iScience. 24(9). 103006–103006. 17 indexed citations
11.
Tang, Juanjie, Supriya Ravichandran, Youri Lee, et al.. (2021). Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients. Nature Communications. 12(1). 1221–1221. 50 indexed citations
12.
Ravichandran, Supriya, Juanjie Tang, Gabrielle Grubbs, et al.. (2021). SARS-CoV-2 immune repertoire in MIS-C and pediatric COVID-19. Nature Immunology. 22(11). 1452–1464. 25 indexed citations
13.
Tang, Juanjie, Gabrielle Grubbs, Youri Lee, Hana Golding, & Surender Khurana. (2021). Impact of Convalescent Plasma Therapy on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Profile in Coronavirus Disease 2019 (COVID-19) Patients. Clinical Infectious Diseases. 74(2). 327–334. 9 indexed citations
14.
Ravichandran, Supriya, Gabrielle Grubbs, Juanjie Tang, et al.. (2021). Systemic and mucosal immune profiling in asymptomatic and symptomatic SARS-CoV-2–infected individuals reveal unlinked immune signatures. Science Advances. 7(42). eabi6533–eabi6533. 13 indexed citations
15.
Tang, Juanjie, Gabrielle Grubbs, Youri Lee, et al.. (2021). Antibody affinity maturation and cross-variant activity following SARS-CoV-2 mRNA vaccination: Impact of prior exposure and sex. EBioMedicine. 74. 103748–103748. 11 indexed citations
16.
Ravichandran, Supriya, Elizabeth M. Coyle, Laura Klenow, et al.. (2020). Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits. Science Translational Medicine. 12(550). 118 indexed citations
17.
McLaren, C., Michael S. Williams, F. Marilyn Bozeman, et al.. (1978). Comparative antigenicity and immunogenicity of 1976 influenza virus vaccines: Results of mouse protection experiments. Journal of Biological Standardization. 6(4). 315–330. 7 indexed citations
18.
Eddy, Bernice E., Gabrielle Grubbs, & Robert D. Young. (1964). Tumor Immunity in Hamsters Infected with Adenovirus Type 12 or Simian Vims 40. Experimental Biology and Medicine. 117(2). 575–579. 48 indexed citations
19.
Eddy, Bernice E., Gabrielle Grubbs, & Robert D. Young. (1962). Persistent Infection of Human Carcinoma and Primary Chick Embryo Cell Cultures with Simian Virus 40. Experimental Biology and Medicine. 111(3). 718–722. 9 indexed citations
20.
Eddy, Bernice E., Sarah E. Stewart, & Gabrielle Grubbs. (1958). Influence of Tissue Culture Passage, Storage, Temperature and Drying on Viability of S E polyoma Virus. Experimental Biology and Medicine. 99(2). 289–292. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026